The new platform combines M42’s advanced AI capabilities with Diaverum’s 35 years of renal care expertise to make trusted, personalized kidney-health education more accessible worldwide
Explore MoreM42, a global health leader powered by artificial intelligence (AI), technology and genomics, has been recognized by the Ministry of Health and Prevention (MoHAP)
Explore MoreM42 is strengthening its UAE healthcare portfolio with 100 per cent ownership of United Eastern Medical Services’ assets, while Olive Rock Partners takes 100 per cent ownership of HealthPlus IVF & Women’s Health Abu Dhabi
Explore MoreLaunch groundbreaking effort to advance precision medicine by delivering pharmacogenomic insight at the point of care
Explore MoreM42 formalizes its 12-year presence in the Kingdom at the Global Health Exhibition in Riyadh, reinforcing alignment with Vision 2030 and commitment to preventive, data-driven healthcare
Explore MoreAccredited 12-credit programme will build health informatics capabilities among ICLDEC staff.
Supported by the Department of Health – Abu Dhabi, the collaboration moves a partnership announced in June into clinical evaluat...
M42, the global health leader powered by artificial intelligence (AI), technology and genomics, and the American University in D...
M42’s Insights Research Organization and Solutions (IROS), an Abu Dhabi-based contract research organization and part of the M42...
Collaboration will bring tumor-informed MRD monitoring to Abu Dhabi, starting with a breast cancer pilot at Cleveland Clinic Abu...
CTL’s independent laboratory testing supports transparency, fairness and confidence in honey competitions at the festival.
